Christopher Marohnic
9Patents
2h-index
16Co-inventors
40Inventor score
Filing activity: Dec 23, 2013 → Apr 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9371374B2 | HCV core lipid binding domain monoclonal antibodies | Physics | 3 | Active |
| US9841427B2 | HCV antigen-antibody combination assay and methods and compositions for use therein | Physics | 2 | Active |
| US9790478B2 | HCV NS3 recombinant antigens and mutants thereof for improved antibody detection | Physics | 2 | Active |
| US10444242B2 | Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies | Physics | 0 | Active |
| US10197573B2 | HCV core lipid binding domain monoclonal antibodies | Physics | 0 | Active |
| US10345311B2 | Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies | Physics | 0 | Active |
| US11428694B2 | Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies | Physics | 0 | Active |
| US10816551B2 | Subject anti-HCV antibody detection assays employing NS3 capture peptides | Physics | 0 | Active |
| US11340230B2 | Subject anti-HCV antibody detection assays employing NS3 capture peptides | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.